Postapproval trials versus patient registries: comparability of advanced melanoma patients with brain metastases

Postapproval trials and patient registries have their pros and cons in the generation of postapproval data. No direct comparison between clinical outcomes of these data sources currently exists for advanced melanoma patients. We aimed to investigate whether a patient registry can complement or even...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Melanoma Res
Auteurs principaux: Ismail, Rawa K., Sikkes, Nienke O., Wouters, Michel W.J.M., Hilarius, Doranne L., Pasmooij, Anna M.G., van den Eertwegh, Alfonsus J.M., Aarts, Maureen J.B., van den Berkmortel, Franchette W.P.J., Boers-Sonderen, Marye J., de Groot, Jan Willem B., Haanen, John B.A.G., Hospers, Geke A.P., Kapiteijn, Ellen, Piersma, Djura, van Rijn, Roos S., Suijkerbuijk, Karijn P.M., ten Tije, Bert-Jan, van der Veldt, Astrid A.M., Vreugdenhil, Art, van Dartel, Maaike, de Boer, Anthonius
Format: Artigo
Langue:Inglês
Publié: Lippincott Williams & Wilkins 2020
Sujets:
Original Articles: Clinical Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7757745/
https://ncbi.nlm.nih.gov/pubmed/33351553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000707
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires